A Category 1 designation means there is sufficient evidence to support safe compounding not that the compound is FDA-approved as a drug
Other drugs on the market such as Mounjaro (tirzepatide), which was approved for treating Type 2 diabetes but also seems to help with weight loss, could also see greater interest
Low and elevated dose adjustments Low Dose: 1.6 mg total contains 1 mg GHK-Cu and 200 mcg each of BPC-157, TB-4, and KPV
Lancet Diabetes Endocrinol 7:776785 de Leeuw AE, de Boer RA (2016) Sodium-glucose cotransporter 2 inhibition: cardioprotection by treating diabetes a translational viewpoint explaining its potential salutary effects
However, purchasing from unverified sources may result in counterfeit or inconsistent products
IGF-1 LR3 is made up of components which enhance its longevity and lower interaction processes which may inhibit its functioning